Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fuentes

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Nature|June 4, 2024
Author Correction: Myt1l safeguards neuronal identity by actively repressing many non-neuronal fatesMoritz Mall, Michael S Kareta, Soham Chanda, et al.
Cell|November 19, 2013
Hierarchical mechanisms for direct reprogramming of fibroblasts to neuronsOrly L Wapinski, Thomas Vierbuchen, Kun Qu, et al.
Nature|April 6, 2017
Myt1l safeguards neuronal identity by actively repressing many non-neuronal fatesMoritz Mall, Michael S Kareta, Soham Chanda, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2008
Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinasesGuozhang Xu, Lily Lee Searle, Terry V Hughes, et al.
Journal of Cardiovascular Translational Research|May 5, 2021
Microcirculatory Changes in Pediatric Patients During Congenital Heart Defect Corrective SurgeryRafael González Cortés, Javier Urbano Villaescusa, María J Solana García, et al.
Gastroenterology|February 26, 2022
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer MicroenvironmentCarolina J Garcia Garcia, Yanqing Huang, Natividad R Fuentes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patientsC Balaña, A Estival, I Teruel, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A Multispecies, Modality-Agnostic Scalable In Vivo Mosaic Screening Platform for Therapeutic Target DiscoveryVishwaraj Sontake, Vinay Kartha, Neety Sahu, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Nature|June 4, 2024
Author Correction: Myt1l safeguards neuronal identity by actively repressing many non-neuronal fatesMoritz Mall, Michael S Kareta, Soham Chanda, et al.
Cell|November 19, 2013
Hierarchical mechanisms for direct reprogramming of fibroblasts to neuronsOrly L Wapinski, Thomas Vierbuchen, Kun Qu, et al.
Nature|April 6, 2017
Myt1l safeguards neuronal identity by actively repressing many non-neuronal fatesMoritz Mall, Michael S Kareta, Soham Chanda, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2008
Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinasesGuozhang Xu, Lily Lee Searle, Terry V Hughes, et al.
Journal of Cardiovascular Translational Research|May 5, 2021
Microcirculatory Changes in Pediatric Patients During Congenital Heart Defect Corrective SurgeryRafael González Cortés, Javier Urbano Villaescusa, María J Solana García, et al.
Gastroenterology|February 26, 2022
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer MicroenvironmentCarolina J Garcia Garcia, Yanqing Huang, Natividad R Fuentes, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patientsC Balaña, A Estival, I Teruel, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A Multispecies, Modality-Agnostic Scalable In Vivo Mosaic Screening Platform for Therapeutic Target DiscoveryVishwaraj Sontake, Vinay Kartha, Neety Sahu, et al.
Pageof 15